Keyphrases
Antigen-binding Site
20%
Biophysical Characteristics
20%
Biparatopic
100%
Breadth of Coverage
20%
Broad Neutralization
100%
Chimeric Virus
20%
COVID-19
20%
Diabody
20%
Emergency Department Use
20%
High Potency
20%
Modular Assembly
20%
Modular Platform
20%
Neutralizing Antibodies
80%
New Treatment Options
20%
Rapid Production
20%
SARS-CoV-2 Pseudovirus
20%
SARS-CoV-2 Spike Protein
20%
SARS-CoV-2 Variants
100%
Spike Protein
20%
Tetravalent
100%
Therapeutic Antibody
20%
Trimer
20%
Variants of Concern
20%
Viral Variants
20%
Immunology and Microbiology
COVID-19
25%
Neutralization
100%
Neutralizing Antibody
100%
Paratope
25%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
50%
Therapeutic Antibodies
25%
Virus
25%
Medicine and Dentistry
Antibody Combining Site
25%
COVID-19
25%
Neutralization
100%
Neutralizing Antibody
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Virus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Site
25%
Neutralizing Antibody
100%
SARS Coronavirus
100%